Cabretol 100 mg/5 ml (Oral Suspension)

100 ml bottle: ৳ 301.00

Medicine Details

For adults and children over 12 years of age: initial dosage is either 200 mg b.i.d. for tablets and controlled release tablets, or 1 teaspoon q.i.d. for suspension (400 mg/day)
Children 12-15 years of age: Dosage generally should not exceed 1000 mg daily, and 1200 mg daily in patients above 15 years of age
Children 6-12 years of age: Initial dosage is either 100 mg b.i.d. for tablets or controlled release tablets, or 1/2 teaspoon q.i.d. for suspension (200 mg/day)
Children under 6 years of age: Initial dosage is 10-20 mg/kg/day b.i.d.or t.i.d. as tablets, or q.i.d. as suspension

Galactorrhoea reported in few women on oral contraceptives within the first two months of Cabretol treatment
Hepatic enzyme inducers may interact with Cabretol by increasing its metabolism
Increase in dosage of Cabretol may be required

Problems with the electrical message pathways in the heart (atrioventricular block)
History of decreased blood cell production by the bone marrow (bone marrow depression)
Hereditary blood disorders called porphyrias
Allergy to tricyclic antidepressants
Not to be used by people who have taken a monoamine-oxidase inhibitor antidepressant (MAOI) in the last 14 days

Carbamazepine and its metabolite are transferred to breast milk
Decision should be made whether to discontinue nursing or discontinue the drug due to potential serious side effects

May cause dizziness and drowsiness
May cause skin reactions
May rarely cause liver problems
Decreases the blood levels of hormonal contraceptives containing estrogen and/or progesterone
Should not be stopped suddenly unless the doctor tells
Caution should be taken in mixed seizures including absence seizures, elderly people, history of heart disease, kidney disease, liver disease, psychotic illness, raised pressure in the eye (intraocular pressure), and history of blood disorders caused by any other medication